Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Vasodialators Dispersion-polymers-for-ethylene-quench-water-clarification

 Treatment of bone disorders with adrenomedullin
OF THE INVENTION It is believed that one skilled in the art can, based on the description herein, ...


 99MTC(III) myocardial imaging agents and method of use
OF THE INVENTION The technetium compounds of the present invention which have been found most ...


 1,4-dihydro-4-oxo-3-quinoline derivatives as selectively toxic mammalian antibacterial agents
OF THE INVENTION Compounds of the formula I may be prepared as illustrated in the following ...


 Vaginal sponge delivery system
These and other objects of the invention are achieved in a product which broadly comprises (a) a ...


 Controlled release formulation
What is claimed is: 1. In a controlled release angiotensin converting enzyme inhibitor formulation ...


 Formulations providing three distinct releases
We claim: 1. A therapeutic composition for oral administration consisting essentially of a ...


 Floating sustained release therapeutic compositions
OF THE INVENTION According to the present invention, therapeutic dosage forms have now been ...


 Solid oral dosage forms of ifosfamide
OF PREFERRED EMBODIMENTS The invention is illustrated by the following examples: EXAMPLE 1 I...


 [(benzodioxan, benzofuran or benzopyran) alkylamino] alkyl substituted guanidines
We claim: 1. A compound of the formula: ##STR259## a pharmaceutically acceptable acid addition salt ...


 Methods for treating dermatitis using descarboethoxyloratadine
OF THE INVENTION The present invention encompasses a method of treating allergic asthma in a human ...


 Dispersion polymers for ethylene quench water clarification

Details
Inventors: Byrne, Norman E.; Williams, Belinda K.; Fisher, Sherri L.;
Assignee: Nalco Chemical Company (Naperville, IL)
Primary Examiner: Hruskoci; Peter A.
Assistant Examiner:
Attorney, Agent or Firm: Miller; Robert A., Barrett; Joseph B.

One aspect of the invention provides a method of removing emulsified oil from ethylene quench water. According to the method, the oil-containing water is treated with an effective amount of a dispersion of a water-soluble cationic polymer.

DETAILED DESCRIPTION We claim: 1.
A method of removing emulsified oil from ethylene quench water, the method comprising the step of treating the oil-containing water with an effective amount of a dispersion of a water-soluble cationic polymer, said dispersion of the water-soluble cationic polymer being prepared by polymerizing a water-soluble monomer mixture containing a least 5 mole % of a cationic monomer represented by general formula (I) and at least 5 mole % of acrylamide or methacrylamide in an aqueous solution of a polyvalent anionic salt, said polymerization is carried out in an aqueous solution including from about 1 to about 10 percent by weight based on the total weight of the monomers a dispersant polymer, said dispersant polymer being a water-soluble cationic polymer which is soluble in said aqueous solution of the polyvalent anionic salt and which contains at least 20 mole % of cationic monomer units represented by a general formula (II): ##STR4## wherein R.
sub.
1 and R.
sub.
4 are each H or CH.
sub.
3 ; R.
sub.
2, R.
sub.
3, R.
sub.
5 and R.
sub.
6 are each an alkyl group having 1 to 2 carbon atoms; R.
sub.
7 is a hydrogen atom or an alkyl group having 1 to 2 carbon atoms; A.
sub.
1 and A.
sub.
2 are each an oxygen atom or NH; B.
sub.
1 and B.
sub.
2 are each 2 to 4 carbon atoms or a hydroxypropyl group and X.
sub.
1 - and X.
sub.
2 - are each a counter anion, once treated, the emulsified oil flocculates; and removing the flocculated emulsified oil from the treated ethylene quench water.
2.
The method of claim 1 wherein said aqueous solution further includes a seed polymer; said seed polymer being a water-soluble cationic polymer which is insoluble in said aqueous solution of the polyvalent anionic salt and which contains at least 5 mole % of cationic monomer units represented by the general formula (I).
3.
The method of claim 1 wherein the water-soluble monomer mixture further contains at least 5 mole % of a cationic monomer represented by the general formula (II).
4.
The method of claim 1 wherein the polyvalent anionic salt comprises a phosphate, a sulfate or a mixture thereof



Related patents
  Corneal angiogenesis inhibitor
What is claimed is: 1. A method for treating corneal neovasculariztion which comprises: administering an effective amount of interferon .beta. for treating corneal ...
  Methods and formulations for use in treating oophorectomized women
OF THE INVENTION Pursuant to the present invention, the regimen comprises a slow-release (or depot) formulation which is effective for an extended period of time. D...
  Treatment of sexual dysfunction in certain patient groups
OF THE INVENTION The present invention relates to methods for the treatment of sexual dysfunction in males and females (including but not limited to erectile ...
  ***WITHDRAWN PATENT AS PER THE LATEST USPTO WITHDRAWN LIST*** *** NO IMAGES AVAILABLE*** Compositions, methods and devices for the transdermal delivery of drugs
OF THE INVENTION The present invention provides compositions comprising (i) a gelling agent consisting of methylcellulose or at least one natural gum, or a mixture ...
  Treatment of sexual dysfunction in certain patient groups
OF THE INVENTION The present invention relates to methods for the treatment of sexual dysfunction in males and females (including but not limited to erectile ...
  Methods of inducing analgesia or anesthesia and treating or preventing ischemic injury of tissues in general
This invention is therefore aimed at solving the above-mentioned shortcoming of adenosinergic approaches, while obtaining either analgesic (anesthetic) or protective ...
  Oil composition
What is claimed is: 1. An oil composition, comprising about 0.1 to 59.8% by weight of a triglyceride, about 40 to 99.7% by weight of a diglyceride, about 0.1 to 10% by ...
  Blocking agents of EDRF effect or formation for the treatment of shock
We claim: 1. A therapeutical composition of matter for the treatment by perfusion of shock states comprising as an essential ingredient therein an effective amount of a ...
  Use of polyamines as ionic-channel regulating agents
OF THE PREFERRED EMBODIMENTS The disclosure of any and all cited documents including literature and patent application is incorporated by reference in its entirety. It ...
  Inhibitor of ceramidase
It is a general object of the invention to provide a method of selecting compounds that cause intracellular accumulation of ceramide. It is a specific object of the ...

0.034

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved